1-1 of 1
Kristy Harvey Matte
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ClonoSEQ MRD negativity at day 90 is a strong predictor for progression-free and overall survival after BCMA-directed CAR T-cell therapy for relapsed multiple myeloma.

Free
Brandon Kale, Ariel Grajales-Cruz, Brandon Blue, Gabriel De Avila, David Scheiber-Camoretti, Ariosto Siqueira Silva, Daniel Deavila, Kristy Harvey Matte, Laura Oswald, Lauren Peres, Rebecca Gonzalez, Hien Liu, Kenneth Shain, Rachid Baz, Taiga Nishihori, Melissa Alsina, Ciara Louise Freeman, Frederick Locke, Fabiana Perna, Omar Alexis Castaneda Puglianini, Doris Hansen
Journal: Blood
Blood (2025) 146 (Supplement 1): 5846.
https://doi.org/10.1182/blood-2025-5846
Published: 2025